Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Am J Hematol. 2014 Nov 24;90(3):187–192. doi: 10.1002/ajh.23888

Table 1.

Demographics of children with congenital hemolytic anemia undergoing total splenectomy or partial splenectomy

Overall Hereditary
spherocytosis
Sickle cell
disease
Other p-value
N 100 40 (40%) 50 (50%) 10 (10%)
Demographics
Gender 0.453
  Male 49 (49%) 19 (47.5%) 27 (54%) 3 (30%)
  Female 51 (51%) 21 (52.5%) 23 (46%) 7 (70%)
Race/Ethnicity <0.001
  White 35 (35%) 30 (75%) 0 (0%) 5 (50%)
  Black 53 (53%) 6 (15%) 46 (92%) 1 (10%)
  Hispanic 7 (7%) 3 (7.5%) 4 (8%) 0 (0%)
  Other 5 (5%) 1 (2.5%) 0 (0%) 4 (40%)
Preoperative Vaccinations
Pneumovax 0.001
  Yes/No or unknown 87/13 (87%) 34/6 (85%) 48/2 (96%) 5/5 (50%)
Meningovax or Menactra 0.001
  Yes/No or unknown 80/20 (80%) 30/10 (75%) 46/4 (92%) 4/6 (40%)
Postoperative Antibiotics 0.348
  Yes/No or unknown 98/1 (99%) 38/1 (97%) 50/0 (100%) 10/0 (100%)

Numbers represent counts (%) for each variable in the overall cohort and grouped by diagnosis. P-values represent Pearson’s Chi-square or Fisher’s exact test as appropriate for a difference between the diagnostic groups.